Transient Ischemic Attack News and Research

RSS
A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.
Transient ischemic attacks are treatable and preventable

Transient ischemic attacks are treatable and preventable

Dr. Shelagh Coutts receives award for developing new brain scan

Dr. Shelagh Coutts receives award for developing new brain scan

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

Transient ischemic attack can trigger stroke

Transient ischemic attack can trigger stroke

Merck update on the status of telcagepant clinical development programs

Merck update on the status of telcagepant clinical development programs

Free, online self-assessment quiz helps assess health and lifestyle risks for PAD

Free, online self-assessment quiz helps assess health and lifestyle risks for PAD

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

PLATO study reveals that ticagrelor reduces the rate of cardiovascular events

PLATO study reveals that ticagrelor reduces the rate of cardiovascular events

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Migraines with aura in middle age associated with late-life brain lesions

Migraines with aura in middle age associated with late-life brain lesions

Increased risk of stroke and transient ischemic attack in survivors of Hodgkin lymphoma

Increased risk of stroke and transient ischemic attack in survivors of Hodgkin lymphoma

More patients needed in clinical trials to find treatment for patent foramen ovale (PFO)

More patients needed in clinical trials to find treatment for patent foramen ovale (PFO)

Signs of stroke -  most people ignorant

Signs of stroke - most people ignorant